- Home
- OPK vs REAL Comparison
OPK vs REAL Comparison
Compare OPK & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPK | REAL |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.7B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OPK | REAL |
|---|---|---|
| Price | $1.31 | $14.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $2.28 | ★ $14.94 |
| AVG Volume (30 Days) | ★ 3.1M | 2.8M |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $642,067,000.00 | ★ $662,789,000.00 |
| Revenue This Year | N/A | $17.10 |
| Revenue Next Year | N/A | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.30 |
| 52 Week Low | $1.11 | $4.61 |
| 52 Week High | $2.04 | $16.24 |
Technical Indicators
Market Signals| Indicator | OPK | REAL |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 60.87 |
| Support Level | $1.28 | $14.02 |
| Resistance Level | $1.42 | $15.00 |
| Average True Range (ATR) | 0.05 | 0.67 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 25.16 | 57.14 |
Price Performance
Historical ComparisonAbout OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.